Skip to main content

Find Clinical Trials

Home
Conditions
Neurodevelopmental Disorders

Clinical trial condition

Neurodevelopmental Disorders

Explore clinical trials studying Neurodevelopmental Disorders. Study availability and eligibility vary by location and protocol.

4,081 public trials 628 recruiting studies

Refine in advanced search Browse all conditions

Neurodevelopmental Disorders trial results

Completed

PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations

NCT03265119

Conditions: Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: Aevi Genomic Medicine Wayne, Pennsylvania, United States

View Trial Details

Completed

A Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations

NCT03233867

Conditions: Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: Aevi Genomic Medicine Wayne, Pennsylvania, United States

View Trial Details

Completed

Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD

NCT03006367

Conditions: Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: Meridien Research, Inc. Maitland, Florida, United States

QPS-MRA, LLC (Miami Research Associates) Miami, Florida, United States

Center for Psychiatry and Behavioral Medicine Las Vegas, Nevada, United States

View Trial Details

Completed

An eHealth Intervention for Obsessive Compulsive Disorder in Youth With Autism Spectrum Disorder

NCT03473080

Conditions: Anxiety Disorders, Autism Spectrum Disorder, Child Development Disorders, Pervasive, +3 more
Locations: BUP OCD and Related Disorders Stockholm, Sweden

View Trial Details

Completed

Reduction of Perioperative Anxiety Using a Hand-held Video Game Device

NCT04950088

Conditions: Anxiety, Anxiety Disorders, Anxiety Generalized, +5 more
Locations: Not specified

View Trial Details

Completed

A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD

NCT02811211

Conditions: Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: A.I. DuPont Hospital for Children Wilmington, Delaware, United States

View Trial Details

Completed

Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD

NCT04167189

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: NeurAbilitis Voorhees Township, New Jersey, United States

View Trial Details

Completed

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Children With ADHD

NCT03247530

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: Harmonex Neuroscience Research Dothan, Alabama, United States

Indago Research & Health Center, Inc. Hialeah, Florida, United States

Advanced Clinical Research Meridian, Idaho, United States

Finger Lakes Clinical Research Rochester, New York, United States

View Trial Details

Completed

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD

NCT03247556

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: Alliance for Wellness dba Alliance for Research Long Beach, California, United States

MCB Clinical Research Centers, LLC Colorado Springs, Colorado, United States

Meridien Research at Florida Clinical Research Center Bradenton, Florida, United States

Innovative Clinical Research, Inc Lauderhill, Florida, United States

View all 14 locations

View Trial Details

Completed

Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT01244490

Conditions: Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: Psychiatric Centers at San Diego, Feighner Research San Diego, California, United States

Florida Clinical Research Center, LLC Maitland, Florida, United States

Atlanta Center for Medical Research Atlanta, Georgia, United States

Psychiatric Associates Overland Park, Kansas, United States

View all 66 locations

View Trial Details